AMG
41
-8
GT
36
-10
ISRG
48
-11
DOW
15
-9
BK
43
-15
AAL
26
3
CA
13
-3
MAS
36
-6
CTAS
27
-16
CF
33
-17
STX
24
-6
JWN
46
-3
AXP
45
-4
SHW
50
-8
HPQ
34
-4
UHS
51
-16
WDC
24
-3
VRSN
40
-10
SE
41
-16
HOG
33
-3
AMG
41
-8
GT
36
-10
ISRG
48
-11
DOW
15
-9
BK
43
-15
AAL
26
3
CA
13
-3
MAS
36
-6
CTAS
27
-16
CF
33
-17
STX
24
-6
JWN
46
-3
AXP
45
-4
SHW
50
-8
HPQ
34
-4
UHS
51
-16
WDC
24
-3
VRSN
40
-10
SE
41
-16
HOG
33
-3
Financhill
Back

Legend Biotech 10K Form

Sell
19

LEGN
Legend Biotech

Last Price:
$30.23
Seasonality Move:
27.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LEGN News And Ratings

See the #1 stock for the next 7 days that we like better than LEGN

LEGN Financial Statistics

Sales & Book Value

Annual Sales: $627.2M
Cash Flow: $-84.5M
Price / Cash Flow: 0
Annual Sales: $5.67
Price / Book: 5.65

Profitability

EPS (TTM): -0.98000
Net Income (TTM): $-177M
Gross Margin: $392.7M
Return on Equity: -15.44%
Return on Assets: -10.03%

Legend Biotech Earnings Forecast

Key Legend Biotech Financial Ratios

  • The Gross Profit Margin over the past 5 years for LEGN is 62.60%.
  • The Selling, General & Administrative Expenses for LEGN have been equal to 45.32% of Gross Profit Margin.
  • The Research & Development expenses have been 65.93% of Revenue.
  • The Net Earning history of LEGN is -28.22% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

Legend Biotech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: LEGN
CUSIP: 52490G
Website: legendbiotech.com

Debt

Debt-to-Equity Ratio: 0.29
Current Ratio: 4.62
Quick Ratio: 4.49

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 45.16

LEGN Technical Analysis vs Fundamental Analysis

Sell
19
Legend Biotech (LEGN) is a Sell

Is Legend Biotech a Buy or a Sell?

  • Legend Biotech stock is rated a Sell
    The current Legend Biotech [LEGN] share price is $32.01. The Score for LEGN is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.